Lewis Au

Employment

• Peter MacCallum Cancer Centre Medical Oncologist
• Peter MacCallum Cancer Centre Postdoctoral Researcher
• The University of Melbourne Honorary Fellow

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (71)

• Liquid Biopsy in Biliary Tract Cancer: When Tissue Is Not Enough
  Clinical Cancer Research 2026 DOI: 10.1158/1078-0432.CCR-26-2090
  +Save
• Figure 1 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.28523051
  +Save
• Figure 2 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.28523048
  +Save
• Supplementary Figures 1-33 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701141
  +Save
• Supplementary Note 1 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701138
  +Save
• Supplementary Note 2 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701135
  +Save
• Supplementary Table 1 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701129
  +Save
• Supplementary Table 10 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701126
  +Save
• Supplementary Table 11 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701123
  +Save
• Supplementary Table 2 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701117
  +Save
• Supplementary Table 3 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701108
  +Save
• Supplementary Table 4 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701102
  +Save
• Supplementary Table 5 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701096
  +Save
• Supplementary Table 6 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701087
  +Save
• Supplementary Table 7 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701081
  +Save
• Supplementary Table 8 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701075
  +Save
• Supplementary Table 9 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2026 DOI: 10.1158/2159-8290.32701072
  +Save
• Nuclear Imaging in Renal Cell Carcinoma: Current Evidence and Clinical Applications
  Cancers 2026 DOI: 10.3390/cancers18020195
  +Save
• Data from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2025 DOI: 10.1158/2159-8290.c.7700588
  +Save
• Figure 3 from Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
  2025 DOI: 10.1158/2159-8290.28523045
  +Save